HYPERION THERAPEUTICS INC 4
4 · HYPERION THERAPEUTICS INC · Filed May 8, 2015
Insider Transaction Report
Form 4
Scharschmidt Bruce Frederick
SVP & Chief Medical Officer
Transactions
- Disposition to Issuer
Common Stock
2015-05-07$46.00/sh−18,050$830,300→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−46,000$2,116,000→ 0 totalExercise: $24.26Exp: 2023-04-14→ Common Stock (46,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−24,000$1,104,000→ 0 totalExercise: $25.97Exp: 2025-02-09→ Common Stock (24,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07−27→ 0 totalExercise: $327.95Exp: 2018-04-21→ Common Stock (27 underlying) - Disposition from Tender
Common Stock
2015-05-07$46.00/sh−97,471$4,483,666→ 0 total - Disposition from Tender
Common Stock
2015-05-07$46.00/sh−24,448$1,124,608→ 0 total(indirect: By Trust) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−25,227$1,160,442→ 0 totalExercise: $7.31Exp: 2022-04-15→ Common Stock (25,227 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−32,000$1,472,000→ 0 totalExercise: $26.74Exp: 2024-03-10→ Common Stock (32,000 underlying) - Disposition to Issuer
Common Stock
2015-05-07$46.00/sh−6,975$320,850→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07−191→ 0 totalExercise: $327.95Exp: 2018-03-31→ Common Stock (191 underlying)
Footnotes (5)
- [F1]Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the issuer.
- [F2]Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon (the "Merger").
- [F3]Shares that are being acquired by Horizon in the Merger.
- [F4]Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger.
- [F5]Options to acquire shares of issuer common stock that will be cancelled for no consideration in connection with the Merger.